AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
May 28, 2013
30339_dirs_2013-05-28_568484e2-456e-4133-b817-72f6854dbff3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-05-24
Reporting Person: JOHNSON L ROBERT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-24 | Common Stock | S | 1700.0000 | $67.4700 | Disposed | 21276.9300 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.44 to $67.55, inclusive. The reporting person undertakes to provide to any security holder of West Pharmaceutical Services, Inc. or the staff of the securities and Exchange Commission, upon request, full informatin regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27